Literature DB >> 3862284

Chronic myelocytic leukemia as a secondary malignant condition in a patient receiving prolonged chemotherapy for ovarian carcinoma.

M Markman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3862284      PMCID： PMC1306292     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  10 in total

1.  Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience.

Authors:  W J Tester; T J Kinsella; B Waller; R W Makuch; P A Kelley; E Glatstein; V T DeVita
Journal:  J Clin Oncol       Date:  1984-07       Impact factor: 44.544

2.  Second malignancies associated with chemotherapeutic agents.

Authors:  R A Kyle
Journal:  Semin Oncol       Date:  1982-03       Impact factor: 4.929

3.  Acute leukemia after alkylating-agent therapy of ovarian cancer.

Authors:  R R Reimer; R Hoover; J F Fraumeni; R C Young
Journal:  N Engl J Med       Date:  1977-07-28       Impact factor: 91.245

4.  Second primary neoplasms following ovarian cancer.

Authors:  R R Reimer; R Hoover; J F Fraumeni; R C Young
Journal:  J Natl Cancer Inst       Date:  1978-11       Impact factor: 13.506

Review 5.  Carcinogenicity of antineoplastic agents in man.

Authors:  K Rieche
Journal:  Cancer Treat Rev       Date:  1984-03       Impact factor: 12.111

Review 6.  Second malignant neoplasms associated with immunosuppressive medications.

Authors:  I Penn
Journal:  Cancer       Date:  1976-02       Impact factor: 6.860

7.  Combination intraperitoneal chemotherapy with cisplatin, cytarabine, and doxorubicin for refractory ovarian carcinoma and other malignancies principally confined to the peritoneal cavity.

Authors:  M Markman; S B Howell; W E Lucas; C E Pfeifle; M R Green
Journal:  J Clin Oncol       Date:  1984-12       Impact factor: 44.544

8.  Chronic granulocytic leukemia and carcinoma of the cervix in situ following renal transplantation.

Authors:  R Hilario; T Padre-Mendoza; M M Albala
Journal:  Am J Med Sci       Date:  1980 Sep-Oct       Impact factor: 2.378

9.  Acute non-lymphocytic leukemia in patients with ovarian carcinoma following long-term treatment with Treosulfan (= dihydroxybusulfan).

Authors:  J Pedersen-Bjergaard; N I Nissen; H M Sørensen; K Hou-Jensen; M S Larsen; P Ernst; J Ersbøl; S Knudtzon; C Rose
Journal:  Cancer       Date:  1980-01-01       Impact factor: 6.860

10.  Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: a study of five randomized clinical trials.

Authors:  M H Greene; J D Boice; B E Greer; J A Blessing; A J Dembo
Journal:  N Engl J Med       Date:  1982-12-02       Impact factor: 91.245
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.